← Evidence map

ArticleCurrent oncology (Toronto, Ont.)2026

"HER2-Low" and the Challenge of Repurposing Legacy HER2 IHC Biomarker Assays.

Emina E Torlakovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42041700